Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 04, 2015 1:31 PM ET

Healthcare Equipment and Supplies

Company Overview of Oxford Immunotec Global PLC

Company Overview

Oxford Immunotec Global PLC, a diagnostics company, develops and commercializes proprietary tests for the management of immune-regulated conditions in the United States, Europe, Japan, and China. The company develops its products using its T-SPOT technology platform, which enables the measurement of responses of specific immune cells to inform the diagnosis, prognosis, and monitoring of patients with immunologically controlled diseases. Its solution includes SPOT.TB test, a single-cell based method for identifying latent tuberculosis infection. The company was founded in 2002 and is headquartered in Abingdon, the United Kingdom.

115D Innovation Drive

Milton Park

Abingdon,  OX14 4RZ

United Kingdom

Founded in 2002

270 Employees

Phone:

44 1235 442780

Fax:

44 1235 442781

Key Executives for Oxford Immunotec Global PLC

Chief Executive Officer and Director
Age: 41
Total Annual Compensation: $406.8K
Chief Financial Officer and Principal Accounting Officer
Age: 55
Total Annual Compensation: $255.0K
Chief Operations Officer
Age: 53
Total Annual Compensation: $268.5K
Chief Commercial Officer
Age: 54
Total Annual Compensation: $311.9K
Compensation as of Fiscal Year 2014.

Oxford Immunotec Global PLC Key Developments

Oxford Immunotec Global PLC Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Revenue Guidance for the Third Quarter and Full Year 2015

Oxford Immunotec Global PLC reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported revenue of $14.3 million, representing 21% growth over the second quarter 2014 revenue of $11.8 million. LBITDA was $6.8 million compared to $5.8 million in the second quarter of 2014. Adjusted LBITDA was $6.5 million compared to $4.9 million in the same period in 2014. Net loss was $7.3 million, or $0.33 per share, compared to $6.2 million, or $0.36 per share, in the second quarter of 2014. Loss from operations was $6.61 million compared to $6.03 million a year ago. Loss before income taxes was $7.29 million compared to $6.24 million a year ago. For the six months, total revenue was $28.05 million compared to $24.06 million a year ago. Adjusted LBITDA was $11.52 million compared to $7.32 million a year ago. Loss from operations was $13.13 million compared to $8.97 million a year ago. Loss before income taxes was $13.56 million compared to $9.36 million a year ago. Net loss was $13.61 million or $0.64 per basic and diluted share compared to $9.39 million or $0.54 per basic and diluted share a year ago. The company provided revenue guidance for the third quarter and full year 2015. The company expects to report revenue of between $16.8 and $17.6 million for the third quarter of 2015. The company expects to report full year 2015 revenue of between $61 and $64 million, representing 23%-29% year-over-year growth. The company expects revenue to increase 29% to 35% for the year using constant exchange rates.

Oxford Immunotec Global PLC to Report Q2, 2015 Results on Aug 04, 2015

Oxford Immunotec Global PLC announced that they will report Q2, 2015 results at 9:00 AM, GMT Standard Time on Aug 04, 2015

Oxford Immunotec Global PLC, Q2 2015 Earnings Call, Aug 04, 2015

Oxford Immunotec Global PLC, Q2 2015 Earnings Call, Aug 04, 2015

Similar Private Companies By Industry

Company Name Region
CAMBfix Limited Europe
Attends Healthcare Group Limited Europe
Proventec HealthCare Ltd. Europe
Penlon Limited Europe
Troy Contact Lenses Ltd. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Oxford Immunotec Global PLC, please visit www.oxfordimmunotec.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.